By Fineline Cube 
Shanghai-based OYMotion Technologies Co., Ltd, a high-tech company specializing in brain-computer interface and robotics technology, has reportedly secured close to RMB 100 million (USD 13.9 million) in a Series B++ financing round. The investors include Infinity, ZSCO, and Womeida Capital. The funds will be utilized to expedite the commercialization of its finger joint rehabilitation exoskeleton robot, further refine its intelligent bionic and dexterous hand products, and expand its global market presence.
Company Background and Achievements
Since its establishment in 2015, OYMotion has garnered over 80 patents. Its OHand intelligent bionic hand has received regulatory approval from the U.S. and European Union authorities and is currently being commercialized globally. The company’s ORF neurorehabilitation exoskeleton series is in the regulatory approval process, designed to provide targeted rehabilitation solutions for patients recovering from strokes and peripheral nerve injuries.-Fineline Info & Tech